Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656733 · ClinicalTrials.gov registry record · Phase 4
Nicotine Replacement for Smoking Cessation During Pregnancy
A Phase 4 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 154
- Enrollment target
NCT01656733: Completed Phase 4 study, sponsored by UConn Health.
NCT01656733 is a Phase 4 study that has completed, run by UConn Health. The registered enrollment target is 154 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01656733, a Phase 4 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 154 participants
- Enrollment target
Study Summary
This is a clinical trial to determine if the nicotine inhaler in combination with counseling will help pregnant women quit smoking, and whether it is safe when compared to placebo (an inactive inhaler).
Primary Outcome
Number of participants who self report an average of zero cigarettes smoked per day in preceding 7 days
Interventions
- DRUG Placebo Inhaler
- DRUG Nicotrol Inhaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2012-08 |
| Est. Completion | 2017-10-25 |
| Phase | Phase 4 |
What the finished NCT01656733 record still lists
NCT01656733 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo Inhaler is the first listed.
NCT01656733 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01656733 about?
NCT01656733 is a clinical study titled "Nicotine Replacement for Smoking Cessation During Pregnancy". This is a clinical trial to determine if the nicotine inhaler in combination with counseling will help pregnant women quit smoking, and whether it is safe when compared to placebo (an inactive inhaler).
What is the current status of trial NCT01656733?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2012-08. Estimated completion is 2017-10-25.
What interventions are being tested in trial NCT01656733?
The interventions under investigation include: Placebo Inhaler (DRUG), Nicotrol Inhaler (DRUG).
Who is sponsoring clinical trial NCT01656733?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01656733's enrollment target sits among peer trials
154 528th of 2000 higher than 1,471 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia